Pharmacogenomics

MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis.

Sundbaum JK, Baecklund E, Eriksson N, ..., Kohnke H, Wadelius M

Pharmacogenomics 21 (5) 337-346 [2020-04-00; online 2020-02-06]

Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population.

Hallberg P, Persson M, Axelsson T, ..., Eriksson N, Wadelius M

Pharmacogenomics 18 (3) 201-213 [2017-02-00; online 2017-01-13]

Affiliated researcher

Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy.

Eriksson N, Wallentin L, Berglund L, ..., Yusuf S, Wadelius M

Pharmacogenomics 17 (13) 1425-1439 [2016-08-00; online 2016-08-04]

Affiliated researcher

Novel regulatory variant detected on the VKORC1 haplotype that is associated with warfarin dose.

Cavalli M, Pan G, Nord H, ..., Wadelius C, Wadelius M

Pharmacogenomics 17 (12) 1305-1314 [2016-08-00; online 2016-02-05]

Affiliated researcher

Genome-wide association study of warfarin maintenance dose in a Brazilian sample.

Parra EJ, Botton MR, Perini JA, ..., Hutz MH, Suarez-Kurtz G

Pharmacogenomics 16 (11) 1253-1263 [2015-08-12; online 2015-08-12]

Microtubule-targeting drugs and personalization of cancer treatment.

Rodríguez-Antona C, Gréen H

Pharmacogenomics 12 (4) 449-451 [2011-04-00; online 2011-04-28]